Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A-P Magiorakos,Arjun Srinivasan,R B Carey,Yehuda Carmeli,Matthew E. Falagas,Matthew E. Falagas,Christian G. Giske,Stéphan Juergen Harbarth,Janet F. Hindler,Gunnar Kahlmeter,Barbro Olsson-Liljequist,David L. Paterson,Louis B. Rice,John Stelling,Marc Struelens,Alkiviadis Vatopoulos,J T Weber,Dominique L Monnet +17 more
Reads0
Chats0
TLDR
A group of international experts came together through a joint initiative by the European Centre for Disease Prevention and Control and the Centers for Disease Control and Prevention, to create a standardized international terminology with which to describe acquired resistance profiles in Staphylococcus aureus, Enterococcus spp.About:
This article is published in Clinical Microbiology and Infection.The article was published on 2012-03-01 and is currently open access. It has received 8695 citations till now. The article focuses on the topics: Extensively drug resistant bacteria & Multiple drug resistance.read more
Citations
More filters
Journal ArticleDOI
Antimicrobial resistance in coagulase-positive staphylococci isolated from companion animals in Australia: A one year study.
Sugiyono Saputra,David Jordan,Kate A. Worthing,Jacqueline M. Norris,Hui San Wong,Rebecca Abraham,Rebecca Abraham,Darren J. Trott,Sam Abraham,Sam Abraham +9 more
TL;DR: For example, this paper found that methicillin-resistant coagulase-positive staphylococci (CoPS) have become increasingly recognised as opportunistic pathogens that limit therapeutic options in companion animals.
Journal ArticleDOI
Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study
TL;DR: There is a need for development of strong policies on antibiotic stewardship, antimicrobial surveillance and infection control to help guide empirical antibiotic therapy and prevent the spread of MDR bacteria and antibiotic drug resistance.
Journal ArticleDOI
Epidemiology and clinical outcomes of multidrug-resistant, gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period.
Laura Folgori,Susanna Livadiotti,Michaela Carletti,Julia Bielicki,Giuseppe Pontrelli,Marta Ciofi Degli Atti,Chiara Bertaina,Barbara Lucignano,Stefania Ranno,Edoardo Carretto,Maurizio Muraca,Mike Sharland,Paola Bernaschi +12 more
TL;DR: This study demonstrates the high mortality of hospital-acquired MDRGN bacteremia in children and study of novel antibiotics active against Gram-negative bacteria should include children early in the clinical trial development programs.
Journal ArticleDOI
Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15
Sun Hee Park,Ji-Hyun Byun,Su-Mi Choi,Dong-Gun Lee,Si-Hyun Kim,Jae-Cheol Kwon,Chulmin Park,Jung-Hyun Choi,Jin-Hong Yoo +8 more
TL;DR: A hospital epidemic caused by the dissemination of an epidemic strain, ST131-PFGE type 10, characterized by multidrug resistance and co-producing both CTX-Ms with OXA-1 or TEM-1b is identified, suggesting the widespread of this epidemic clone in Korea.
Journal ArticleDOI
Antibiotic resistance among Escherichia coli isolates from stool samples of children aged 3 to 14 years from Ujjain, India.
Pragya Shakya,Peter Barrett,Vishal Diwan,Yogyata Marothi,Harshada Shah,Neeraj Chhari,Ashok J. Tamhankar,Ashish Pathak,Ashish Pathak,Cecilia Stålsby Lundborg +9 more
TL;DR: Antibiotic resistance and cross-resistance were common in E. coli from stools of children from Ujjain, Central India, and resistance rates were associated with maternal literacy.
References
More filters
Journal ArticleDOI
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher,George H. Talbot,John S. Bradley,John S. Bradley,John E. Edwards,John E. Edwards,David N. Gilbert,Louis B. Rice,Louis B. Rice,Michael Scheld,Brad Spellberg,Brad Spellberg,John G. Bartlett +12 more
TL;DR: An update on potentially effective antibacterial drugs in the late-stage development pipeline is provided, in the hope of encouraging collaboration between industry, academia, the National Institutes of Health, the Food and Drug Administration, and the Centers for Disease Control and Prevention work productively together.
Journal ArticleDOI
Antimicrobial-Resistant Pathogens Associated with Healthcare- Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert,Philip Ricks,Jonathan R. Edwards,Amy Schneider,Jean B. Patel,Arjun Srinivasan,Alex Kallen,Brandi Limbago,Scott K. Fridkin +8 more
TL;DR: The frequency of selected antimicrobial resistance patterns among pathogens causing device-associated and procedure-associated healthcare-associated infections reported by hospitals in the National Healthcare Safety Network (NHSN) is described.
Journal ArticleDOI
Comparison of mortality associated with methicillin-resistant and methicillin-susceptible staphylococcus aureus bacteremia: A meta-analysis
Sara E. Cosgrove,George Sakoulas,Eli N. Perencevich,Mitchell J. Schwaber,Adolf W. Karchmer,Yehuda Carmeli,Yehuda Carmeli +6 more
TL;DR: A meta-analysis was performed to summarize the impact of methicillin-resistance on mortality in Staphylococcus aureus bacteremia and explored the reasons for heterogeneity by means of subgroup analyses.
Journal ArticleDOI
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
TL;DR: More rapid diagnostic testing of ESBL-producing bacteria and the possible modification of guidelines for community-onset bacteraemia associated with UTIs are required.
Journal ArticleDOI
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
TL;DR: The data suggest that clinical efforts should be aimed at reducing the administration of inadequate antimicrobial treatment to hospitalized patients with bloodstream infections, especially individuals infected with antibiotic-resistant bacteria and Candida species.